Free Trial

Bionomics (BNOX) Competitors

Bionomics logo
$0.25 +0.01 (+4.20%)
(As of 12/23/2024 05:45 PM ET)

BNOX vs. CTXR, TENX, CGTX, FNCH, CARM, MIRA, UBX, CVKD, PIRS, and SYBX

Should you be buying Bionomics stock or one of its competitors? The main competitors of Bionomics include Citius Pharmaceuticals (CTXR), Tenax Therapeutics (TENX), Cognition Therapeutics (CGTX), Finch Therapeutics Group (FNCH), Carisma Therapeutics (CARM), MIRA Pharmaceuticals (MIRA), Unity Biotechnology (UBX), Cadrenal Therapeutics (CVKD), Pieris Pharmaceuticals (PIRS), and Synlogic (SYBX). These companies are all part of the "pharmaceutical products" industry.

Bionomics vs.

Citius Pharmaceuticals (NASDAQ:CTXR) and Bionomics (NASDAQ:BNOX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, risk, institutional ownership, valuation, earnings, community ranking and analyst recommendations.

Bionomics' return on equity of 0.00% beat Citius Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Citius PharmaceuticalsN/A -44.65% -39.39%
Bionomics N/A N/A N/A

Citius Pharmaceuticals received 189 more outperform votes than Bionomics when rated by MarketBeat users. However, 76.92% of users gave Bionomics an outperform vote while only 62.20% of users gave Citius Pharmaceuticals an outperform vote.

CompanyUnderperformOutperform
Citius PharmaceuticalsOutperform Votes
209
62.20%
Underperform Votes
127
37.80%
BionomicsOutperform Votes
20
76.92%
Underperform Votes
6
23.08%

Citius Pharmaceuticals has a beta of 1.49, suggesting that its stock price is 49% more volatile than the S&P 500. Comparatively, Bionomics has a beta of 0.27, suggesting that its stock price is 73% less volatile than the S&P 500.

Bionomics has higher revenue and earnings than Citius Pharmaceuticals.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Citius PharmaceuticalsN/AN/A-$32.54M-$6.00-0.52
Bionomics$10K446.82-$15.49MN/AN/A

In the previous week, Bionomics had 4 more articles in the media than Citius Pharmaceuticals. MarketBeat recorded 5 mentions for Bionomics and 1 mentions for Citius Pharmaceuticals. Bionomics' average media sentiment score of 0.57 beat Citius Pharmaceuticals' score of 0.00 indicating that Bionomics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Citius Pharmaceuticals
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Bionomics
1 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

16.9% of Citius Pharmaceuticals shares are owned by institutional investors. Comparatively, 15.9% of Bionomics shares are owned by institutional investors. 15.0% of Citius Pharmaceuticals shares are owned by insiders. Comparatively, 0.7% of Bionomics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Citius Pharmaceuticals currently has a consensus target price of $100.00, suggesting a potential upside of 3,094.89%. Bionomics has a consensus target price of $8.00, suggesting a potential upside of 3,060.81%. Given Citius Pharmaceuticals' higher probable upside, research analysts plainly believe Citius Pharmaceuticals is more favorable than Bionomics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Citius Pharmaceuticals
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.00
Bionomics
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Bionomics beats Citius Pharmaceuticals on 8 of the 14 factors compared between the two stocks.

Get Bionomics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BNOX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BNOX vs. The Competition

MetricBionomicsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$4.47M$6.71B$5.22B$9.27B
Dividend YieldN/A3.00%5.12%4.30%
P/E RatioN/A10.5487.3417.27
Price / Sales446.82195.831,166.41119.61
Price / CashN/A57.1443.2337.83
Price / Book0.195.164.834.93
Net Income-$15.49M$151.58M$120.46M$225.34M
7 Day Performance-3.40%4.12%2.84%4.14%
1 Month Performance-10.02%-3.99%19.70%1.16%
1 Year Performance-80.68%10.33%30.57%16.98%

Bionomics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BNOX
Bionomics
2.7685 of 5 stars
$0.25
+4.2%
$8.00
+3,060.8%
-80.7%$4.47M$10,000.000.00N/AGap Up
High Trading Volume
CTXR
Citius Pharmaceuticals
1.72 of 5 stars
$2.75
-1.4%
$100.00
+3,536.4%
-84.3%$19.88MN/A-0.4720News Coverage
TENX
Tenax Therapeutics
1.4985 of 5 stars
$5.80
-1.4%
$16.00
+175.9%
-77.1%$19.78MN/A0.009Gap Up
CGTX
Cognition Therapeutics
2.9633 of 5 stars
$0.46
-3.1%
$8.00
+1,627.9%
-61.9%$19.24MN/A-0.4920
FNCH
Finch Therapeutics Group
N/A$11.75
-2.1%
N/A+203.4%$18.87M$110,000.00-1.36190
CARM
Carisma Therapeutics
3.3865 of 5 stars
$0.45
+11.4%
$4.94
+995.1%
-87.2%$18.83M$20.27M-0.2620Gap Down
High Trading Volume
MIRA
MIRA Pharmaceuticals
2.4532 of 5 stars
$1.12
flat
$14.00
+1,150.0%
+0.9%$18.55MN/A-2.002Analyst Revision
UBX
Unity Biotechnology
3.1506 of 5 stars
$1.10
-1.8%
$8.00
+627.3%
-37.5%$18.54M$240,000.00-0.8460
CVKD
Cadrenal Therapeutics
1.7675 of 5 stars
$11.06
-1.3%
$18.00
+62.7%
N/A$18.35MN/A-1.684
PIRS
Pieris Pharmaceuticals
1.3297 of 5 stars
$13.60
-15.7%
N/A+7.9%$17.95M$42.81M-1.12140Gap Down
SYBX
Synlogic
N/A$1.50
flat
N/A-61.8%$17.55M$3.37M-0.366

Related Companies and Tools


This page (NASDAQ:BNOX) was last updated on 12/25/2024 by MarketBeat.com Staff
From Our Partners